Krishnendu Pal

5PUBLICATIONS
9CO-AUTHORS
Pharmaceutical delivery technologiesGene and molecular therapyRadiation therapyOptical technologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
Amphiphilic Glycopolymer Nanoparticles for pH-Responsive Paclitaxel Delivery and Enhanced Efficacy in Pancreatic Ductal Adenocarcinoma Therapy.

|Mar 19, 2026
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme.

Ramcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka

|Dec 03, 2025
Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancer.

Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, Shamit Kumar Dutta

|Nov 26, 2025
Structural and Functional Perspectives of Optineurin in Autophagy, Immune Signaling, and Cancer.

Gianluca Medigovic, Hari Krishnareddy Rachamala, Shamit Kumar Dutta

|Oct 03, 2019
Molecular Inhibitor of QSOX1 Suppresses Tumor Growth <i>In Vivo</i>.

Amber L Fifield, Paul D Hanavan, Douglas O Faigel

Pageof 1

Frequent Collaborators

2 joint publications

Debabrata Mukhopadhyay

1 joint publications

Amber L Fifield

1 joint publications

Nathalie Meurice

1 joint publications

Thai H Ho